Form 4 for IMNM Immunome Inc.
Accepted 2025-03-28 00:00:00 ET · period of report 2025-03-27 · accession 0001415889-25-009201 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-28 | 2025-03-27 | IMNM | Higgins Jack | CSO | M - OptEx | $1.35 | +5,200 | 18.7K | +38% | +$7,020 |
| D | 2025-03-28 | 2025-03-27 | IMNM | Higgins Jack | CSO | M - OptEx | $0.00 | -5,200 | 173.8K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-27 | M | A | 5,200 | $1.35 | 18,729 | D | — | — | |
| 2 | Derivative | Employee Stock option (right to buy) | 2025-03-27 | M | D | 5,200 | $0.00 | 173,840 | D | $1.35 · — to 2032-06-23 | 5,200 Common Stock | (F1) 25% of the shares vested on May 1, 2023, and the remaining shares shall vest in 36 equal monthly installments thereafter. |